19 Apr Call for Proposals
$600,000 in Research Grants Available
Letter of Intent Deadline: May 15, 2021
Dysautonomia International is pleased to announce the availability of $600,000 in research grants during our 2021 grant cycle. Up to $500,000 is available from our POTS Research Fund and up to $100,000 is available from our Dysautonomia Research Fund, which focuses on other autonomic disorders. To date, we have funded over $2,000,000 in cutting-edge research grants in five countries, and we can’t wait to see what amazing research applications we will receive this year. Innovative research is urgently needed to better understand autonomic disorders and develop more effective treatment options for millions of people living with autonomic disorders around the world.
Our 2021 POTS Research Fund priorities include:
- imaging studies that explore structural neurological, vascular, and orthopedic findings that may contribute to POTS symptoms;
- studies identifying new biomarkers or better explaining the role of existing biomarkers in POTS;
- neuropathological findings in POTS;
- studies exploring the safety and efficacy of new or existing pharmacological treatment approaches in POTS;
- studies exploring dietary approaches to POTS management;
- studies exploring biological mechanisms that may explain co-morbidity relationships in POTS (e.g., EDS, MCAS, CSF leaks, autoimmune diseases, etc.);
- the development of POTS research tools and infrastructure, especially those needed to support collaborative multi-center studies; and
- studies addressing racial disparities in POTS clinical care or research.
Our 2021 Dysautonomia Research Fund priorities are similar, and focused on other autonomic disorders, including:
- neurocardiogenic syncope
- inappropriate sinus tachycardia
- idiopathic orthostatic intolerance
- autoimmune autonomic ganglionopathies
- autoimmune autonomic neuropathies
- idiopathic autonomic neuropathies (including small fiber neuropathies)
- gastrointestinal disorders due to autonomic dysfunction or autonomic neuropathy
Please read the funding announcements for complete details: